The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(6-(1,7-diazaspiro[3.5]nonan-1-yl)thiazolo[4,5-c]pyridazin-3-yl)-5-(1H-pyrazol-4-yl)phenol ID: ALA4761459
PubChem CID: 150372350
Max Phase: Preclinical
Molecular Formula: C21H21N7OS
Molecular Weight: 419.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Oc1cc(-c2cn[nH]c2)ccc1-c1cc2sc(N3CCC34CCNCC4)nc2nn1
Standard InChI: InChI=1S/C21H21N7OS/c29-17-9-13(14-11-23-24-12-14)1-2-15(17)16-10-18-19(27-26-16)25-20(30-18)28-8-5-21(28)3-6-22-7-4-21/h1-2,9-12,22,29H,3-8H2,(H,23,24)
Standard InChI Key: GXZKNIWTWBZQSS-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 35 0 0 0 0 0 0 0 0999 V2000
31.7219 -1.9068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7178 -1.0896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0119 -0.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3056 -1.0967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.3098 -1.9139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0202 -2.3212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8426 -7.1442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2591 -7.9633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2563 -7.1406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5477 -6.7353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5424 -5.9210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2505 -5.5109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8302 -4.7023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8357 -5.5173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5390 -4.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2460 -4.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8533 -4.1500 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.5217 -3.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7094 -3.4885 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5495 -8.3727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8417 -7.9668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9308 -2.6962 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7242 -2.4871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5133 -1.6976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9625 -6.7293 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.5530 -9.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8925 -9.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1460 -10.4498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9632 -10.4487 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2146 -9.6712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 21 2 0
20 8 2 0
8 9 1 0
9 10 2 0
10 7 1 0
11 12 2 0
12 16 1 0
15 13 1 0
13 14 2 0
14 11 1 0
10 11 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
20 21 1 0
18 22 1 0
22 23 1 0
23 24 1 0
24 1 1 0
1 22 1 0
9 25 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 1 0
30 26 2 0
20 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 419.51Molecular Weight (Monoisotopic): 419.1528AlogP: 3.18#Rotatable Bonds: 3Polar Surface Area: 102.85Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.06CX Basic pKa: 9.96CX LogP: 1.05CX LogD: 0.40Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.47Np Likeness Score: -0.67